Shared on 07 May 26
Fair value Increased 28%26 viewsusers have viewed this narrative update
EvaxionEVAX
Fair Value
US$20.25
Share price07 May
US$3.284.2% undervalued intrinsic discount
1Y24.03%
7D-6.16%
The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)
TA
"Any sufficiently advanced technology is indistinguishable from magic." — I invest in making that magic real. Focused purely on the shift from Science Fiction to Science Fact. No specific sector. Just paradigm shifts.
Published
02 Dec 25
Updated
07 May 26
Views
178
Invested